Overview Dividends

(MMC) Marsh & McLennan Companies - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US5717481023

Insurance Broking, Risk Advisory, Consulting, Reinsurance, Health Benefits

Insurance Brokers
Market Cap in USD: 92,017m

IPO / Inception: 1987-12-30
Return 12m vs S&P 500: -21.0%

EPS (Earnings per Share)

EPS CAGR: 8.55%
EPS Trend: 45.1%

Last SUE: 1.40
Qual. Beats: 4

Revenue

Rev. CAGR: 5.82%
Rev. Trend: 79.4%

Last SUE: 0.47
Qual. Beats: 0

Dividends

Dividend Yield	1.84%
Yield on Cost 5y	3.21%
Yield CAGR 5y	13.47%
Payout Consistency	91.1%
Payout Ratio	36.1%

Risk via 5d forecast
Volatility	15.7%
Value at Risk 5%th	26.2%
Relative Tail Risk	1.41%

Reward TTM
Sharpe Ratio	-0.69
Alpha	-18.96
CAGR/Max DD	0.19

Character TTM
Hurst Exponent	0.431
Beta	0.337
Beta Downside	0.278

Drawdowns 3y
Max DD	27.07%
Mean DD	5.62%
Median DD	2.91%

Description: MMC Marsh & McLennan Companies December 02, 2025

Marsh & McLennan Companies (MMC) is a global professional-services firm that delivers risk, strategy and people solutions through two primary divisions: Risk & Insurance Services, which provides risk-advice, risk-transfer, broking, analytics and program-management services; and Consulting, which offers health, wealth, career, and specialized management, strategic, economic and brand advisory services. Founded in 1871 and headquartered in New York, the company serves corporate, public-sector, insurance, association, professional-services and private-client customers worldwide.

Key performance indicators from the most recent fiscal year (2023) show total revenue of roughly $21.6 billion, with the Risk & Insurance Services segment contributing about 62 % of revenue and delivering an operating margin of 13 %. The Consulting segment, while smaller (≈ 38 % of revenue), has been growing at a 5-6 % annual rate, driven by rising demand for ESG-related risk consulting and workforce-transformation services. A sector-wide driver is the tightening of corporate balance sheets amid higher interest rates, which increases the appetite for sophisticated risk-transfer and cost-optimization solutions.

If you’re looking to deepen the quantitative analysis of MMC’s valuation dynamics, a quick look at ValueRay’s data dashboard can surface additional forward-looking metrics and scenario models to inform your research.

Piotroski VR‑10 (Strict, 0-10) 7.0

Net Income (4.13b TTM) > 0 and > 6% of Revenue (6% = 1.59b TTM)

FCFTA 0.09 (>2.0%) and ΔFCFTA 1.14pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 9.83% (prev 11.20%; Δ -1.37pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.09 (>3.0%) and CFO 5.34b > Net Income 4.13b (YES >=105%, WARN >=100%)

Net Debt (18.91b) to EBITDA (7.25b) ratio: 2.61 <= 3.0 (WARN <= 3.5)

Current Ratio 1.12 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (494.0m) change vs 12m ago -0.40% (target <= -2.0% for YES)

Gross Margin 42.28% (prev 43.06%; Δ -0.78pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 48.70% (prev 48.02%; Δ 0.67pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 6.66 (EBITDA TTM 7.25b / Interest Expense TTM 956.0m) >= 6 (WARN >= 3)

Altman Z'' 3.11

(A) 0.04 = (Total Current Assets 23.70b - Total Current Liabilities 21.10b) / Total Assets 58.78b

(B) 0.46 = Retained Earnings (Balance) 26.95b / Total Assets 58.78b

(D) 0.51 = Book Value of Equity 22.07b / Total Liabilities 43.42b

Total Rating: 3.11 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 79.87

1. Piotroski 7.0pt

2. FCF Yield 4.61%

3. FCF Margin 19.33%

4. Debt/Equity 1.41

5. Debt/Ebitda 2.61

6. ROIC - WACC (= 7.78)%

7. RoE 28.30%

8. Rev. Trend 79.43%

9. EPS Trend 45.14%

What is the price of MMC shares?

As of December 18, 2025, the stock is trading at USD 186.36 with a total of 2,912,666 shares traded.
Over the past week, the price has changed by +3.00%, over one month by +3.04%, over three months by -5.17% and over the past year by -11.18%.

Is MMC a buy, sell or hold?

Marsh & McLennan Companies has received a consensus analysts rating of 3.30. Therefor, it is recommend to hold MMC.

Strong Buy: 4
Buy: 1
Hold: 12
Sell: 3
Strong Sell: 0

What are the forecasts/targets for the MMC price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	211.6	13.6%
Analysts Target Price	211.6	13.6%
ValueRay Target Price	185.3	-0.6%

MMC Fundamental Data Overview December 18, 2025

Market Cap USD = 92.02b (92.02b USD * 1.0 USD.USD)
P/E Trailing = 22.4156
P/E Forward = 18.0832
P/S = 3.4785
P/B = 6.0556
P/EG = 1.8633
Beta = 0.751
Revenue TTM = 26.45b USD
EBIT TTM = 6.37b USD
EBITDA TTM = 7.25b USD
Long Term Debt = 18.32b USD (from longTermDebt, last quarter)
Short Term Debt = 1.59b USD (from shortTermDebt, last quarter)
Debt = 21.43b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 18.91b USD (from netDebt column, last quarter)
Enterprise Value = 110.93b USD (92.02b + Debt 21.43b - CCE 2.51b)
Interest Coverage Ratio = 6.66 (Ebit TTM 6.37b / Interest Expense TTM 956.0m)
FCF Yield = 4.61% (FCF TTM 5.11b / Enterprise Value 110.93b)
FCF Margin = 19.33% (FCF TTM 5.11b / Revenue TTM 26.45b)
Net Margin = 15.60% (Net Income TTM 4.13b / Revenue TTM 26.45b)
Gross Margin = 42.28% ((Revenue TTM 26.45b - Cost of Revenue TTM 15.27b) / Revenue TTM)
Gross Margin QoQ = 38.69% (prev 44.15%)
Tobins Q-Ratio = 1.89 (Enterprise Value 110.93b / Total Assets 58.78b)
Interest Expense / Debt = 1.11% (Interest Expense 237.0m / Debt 21.43b)
Taxrate = 25.05% (253.0m / 1.01b)
NOPAT = 4.78b (EBIT 6.37b * (1 - 25.05%))
Current Ratio = 1.12 (Total Current Assets 23.70b / Total Current Liabilities 21.10b)
Debt / Equity = 1.41 (Debt 21.43b / totalStockholderEquity, last quarter 15.15b)
Debt / EBITDA = 2.61 (Net Debt 18.91b / EBITDA 7.25b)
Debt / FCF = 3.70 (Net Debt 18.91b / FCF TTM 5.11b)
Total Stockholder Equity = 14.58b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.02% (Net Income 4.13b / Total Assets 58.78b)
RoE = 28.30% (Net Income TTM 4.13b / Total Stockholder Equity 14.58b)
RoCE = 19.37% (EBIT 6.37b / Capital Employed (Equity 14.58b + L.T.Debt 18.32b))
RoIC = 13.83% (NOPAT 4.78b / Invested Capital 34.53b)
WACC = 6.05% (E(92.02b)/V(113.44b) * Re(7.26%) + D(21.43b)/V(113.44b) * Rd(1.11%) * (1-Tc(0.25)))
Discount Rate = 7.26% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.40%
[DCF Debug] Terminal Value 79.75% ; FCFE base≈4.58b ; Y1≈5.09b ; Y5≈6.66b
Fair Price DCF = 236.2 (DCF Value 115.71b / Shares Outstanding 489.9m; 5y FCF grow 12.84% → 3.0% )
EPS Correlation: 45.14 | EPS CAGR: 8.55% | SUE: 1.40 | # QB: 4
Revenue Correlation: 79.43 | Revenue CAGR: 5.82% | SUE: 0.47 | # QB: 0
EPS next Quarter (2026-03-31): EPS=3.24 | Chg30d=+0.001 | Revisions Net=+2 | Analysts=19
EPS next Year (2026-12-31): EPS=10.32 | Chg30d=-0.002 | Revisions Net=-2 | Growth EPS=+7.5% | Growth Revenue=+5.1%

Additional Sources for MMC Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle